Nov 18, 2013, 01.29 PM IST Vivimed Labs has reported a sales turnover of Rs 307.28 crore and a net profit of Rs 16.38 crore for the quarter ended Sep '13 Like this story, share it with millions of investors on M3 Vivimed Labs consolidated Sep '13 sales at Rs 307.28 crore Vivimed Labs has reported a sales turnover of Rs 307.28 crore and a net profit of Rs 16.38 crore for the quarter ended Sep '13 Like this story, share it with millions of investors on M3 Vivimed Labs consolidated Sep '13 sales at Rs 307.28 crore Vivimed Labs has reported a sales turnover of Rs 307.28 crore and a net profit of Rs 16.38 crore for the quarter ended Sep '13 Share . Email . Print . A+A- Vivimed Labs has reported a consolidated sales turnover of Rs 307.28 crore and a net profit of Rs 16.38 crore for the quarter ended Sep '13.
| For the quarter ended Sep 2012 the consolidated sales turnover was Rs 275.83 crore and net profit was Rs 25.54 crore.
| | Vivimed Labs shares closed at 176.05 on November 14, 2013 (NSE) and has given -38.74% returns over the last 6 months and -49.95% over the last 12 months. |
| | | Vivimed Labs | | Consolidated Quarterly Results | -------- in Rs. Cr. -------- |
| | Sep '13 | Jun '13 | Mar '13 | | | | Sales Turnover | 307.28 | 343.91 | 296.13 | | | | Other Income | -- | -- | -- | | | | Total Income | 307.28 | 343.91 | 296.13 | | | | Total Expenses | 254.89 | 295.08 | 250.92 | | | | Operating Profit | 52.39 | 48.83 | 45.21 | | | | Profit On Sale Of Assets | -- | -- | -- | | | | Profit On Sale Of Investments | -- | -- | -- | | | | Gain/Loss On Foreign Exchange | -- | -- | -- | | | | VRS Adjustment | -- | -- | -- | | | | Other Extraordinary Income/Expenses | -- | -- | -- | | | | Total Extraordinary Income/Expenses | -- | -- | -- | | | | Tax On Extraordinary Items | -- | -- | -- | | | | Net Extra Ordinary Income/Expenses | -- | -- | -- | | | | Gross Profit | 52.39 | 48.83 | 45.21 | | | | Interest | 17.15 | 9.86 | 5.02 | | | | PBDT | 35.24 | 38.97 | 40.19 | | | | Depreciation | 17.37 | 14.65 | 16.32 | | | | Depreciation On Revaluation Of Assets | -- | -- | -- | | | | PBT | 17.87 | 24.32 | 23.87 | | | | Tax | 1.49 | 4.34 | 8.88 | | | | Net Profit | 16.38 | 19.98 | 14.99 | | | | Minority Interest | -- | -- | -- | | | | Share Of P/L Of Associates | -- | -- | -- | | | | Net P/L After Minority Interest & Share Of Associates | 16.38 | 19.98 | 14.99 | | | | Prior Years Income/Expenses | -- | -- | -- | | | | Depreciation for Previous Years Written Back/ Provided | -- | -- | -- | | | | Dividend | -- | -- | -- | | | | Dividend Tax | -- | -- | -- | | | | Dividend (%) | -- | -- | -- | | | | Earnings Per Share | 10.11 | 12.44 | 9.33 | | | | Book Value | -- | -- | -- | | | | Equity | 16.20 | 16.06 | 16.06 | | | | Reserves | -- | -- | -- | | | | Face Value | 10.00 | 10.00 | 10.00 | | | | Source : Dion Global Solutions Limited |
|
| |
Anda sedang membaca artikel tentang
Vivimed Labs consolidated Sep '13 sales at Rs 307.28 crore
Dengan url
http://sehatgayahidup.blogspot.com/2013/11/vivimed-labs-consolidated-sep-13-sales.html?m=0
Anda boleh menyebar luaskannya atau mengcopy paste-nya
Vivimed Labs consolidated Sep '13 sales at Rs 307.28 crore
namun jangan lupa untuk meletakkan link
Vivimed Labs consolidated Sep '13 sales at Rs 307.28 crore
sebagai sumbernya
Related Posts on
0 komentar:
Posting Komentar